Ironwood Pharmaceuticals Inc (IRWD)
Ironwood - Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
Ironwood - Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive financial catalyst • High potential for stock growth **Sentiment:** Positive (95%) **Content type:** Financial